These data suggested that the protease inhibitor attenuated cardiac fibrosis inhibition induced by LRP6 overexpression due to the decreased degradation of Wnt5a and Wnt11 in CMs of LRP6-overexpressing mice after TAC. This evidence concerns the gene LRP6 and persistent truncus arteriosus.